M&A Deal Summary

ImmunoPrecise Acquires Carterra s LSA Instrument

On March 20, 2024, ImmunoPrecise acquired technology hardware company Carterra s LSA Instrument from Carterra

Acquisition Highlights
  • This is ImmunoPrecise’s 1st transaction in the Technology Hardware sector.
  • This is ImmunoPrecise’s 1st transaction in the United States.
  • This is ImmunoPrecise’s 1st transaction in Utah.

M&A Deal Summary
Date 2024-03-20
Target Carterra s LSA Instrument
Sector Technology Hardware
Buyer(s) ImmunoPrecise
Sellers(s) Carterra
Deal Type Divestiture

Target

Carterra s LSA Instrument

Salt Lake City, Utah, United States
Carterra's LSA Instrument which allows for high throughput surface plasmon resonance-based antibody characterizations thereby significantly increasing the Company’s capacity in performing various label-free protein interaction analyses including best-in-class kinetics, epitope binning, quantitation, epitope mapping, and blocking/neutralization assays.

Search 192,723 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

ImmunoPrecise

Victoria, British Columbia, Canada

website

Category Company
Founded 1983
Sector Life Science
Employees85
Revenue 19M CAD (2022)
DESCRIPTION

ImmunoPrecise is a full-service, therapeutic antibody discovery company focused on the next generation of antibody discovery, to deliver the most therapeutically-relevant antibodies, in a shorter period of time, with the highest probability of succeeding to clinical trials. ImmunoPrecise was founded in 1983 and is based in Victoria, Canada.

DEAL STATS #
Overall 3 of 3
Sector (Technology Hardware) 1 of 1
Type (Divestiture) 1 of 1
State (Utah) 1 of 1
Country (United States) 1 of 1
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-03-29 BioStrand

Diepenbeek , Belgium

BioStrand is a provider of cloud-based solution to perform multi-omics research faster and more accurately, with more effective data analysis. BioStrand is based in Diepenbeek, Belgium.

Buy €20M

Seller(S) 1

SELLER

Carterra

Salt Lake City, Utah, United States

website

Category Company
Founded 2005
Sector Medical Products
DESCRIPTION

Carterra is a provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates. Carterra’s high throughput LSA™ instrument for monoclonal antibody (mAb) screening and characterization combines patented microfluidics technology with real-time High Throughput Surface Plasmon Resonance (HT-SPR) and industry-leading Kinetic and Epitope analysis and visualization software, delivering up to 100 times the throughput in 10% of the time while using only 1% of the sample compared to existing platforms. Carterra was founded in 2005 and is based in Salt Lake City, Utah.

DEAL STATS #
Overall 2 of 2
Sector (Technology Hardware) 1 of 1
Type (Divestiture) 2 of 2
State (Utah) 2 of 2
Country (United States) 2 of 2
Year (2024) 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2022-04-20 Carterra LSA Instrument

Salt Lake City, Utah, United States

Carterra LSA Instrument provides an antibody discovery and characterization platform utilizing Surface Plasmon Resonance (HT-SPR) technology and has quickly made it the standard in 16 of the largest 20 pharmaceutical companies, biotechs, CROs, and government labs.

Sell -
Mergr

Product

Company

Legal